A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 5, 2022

Primary Completion Date

September 20, 2022

Study Completion Date

November 14, 2022

Conditions

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot FlashesHealthy Volunteers

Interventions

DRUG

Elinzanetant (BAY3427080)

Capsule, oral, single dose

DRUG

Dabigatran etexilate

Capsule, oral, single dose

Trial Locations (1)

CRS Clinical Research Services Wuppertal GmbH, Wuppertal